Clinical trial
Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant…
NCT00177710 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00177710 |
|---|---|
| Title | Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study |
| Official title | Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Astellas Pharma US, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Transplantation, Fungal Infections |
| Intervention type | Drug |
| Interventions | Amphotericin B |
| Enrollment | 48 |
| Start date | Jan 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 17, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: